{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:30:14Z","timestamp":1788813014944,"version":"build-2803163510"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>\n                    D-Psicose (DPS) serves as an optimal sucrose substitute, providing only 0.3% of sucrose\u2019s energy content, while exhibiting anti-inflammatory properties and inhibiting lipid synthesis. However, its efficacy in managing non-alcoholic fatty liver disease (NAFLD) remains unclear. This study employed network pharmacology and molecular docking to identify potential DPS targets for NAFLD treatment. A high-fat diet was used to induce a NAFLD mouse model, with DPS administered in drinking water at 5% (high dose DPS group, DPSH group) and 2.5% (low dose DPS group, DPSL group) concentrations. After 12\u202fweeks, blood lipid levels, liver lipid deposition, and inflammation were evaluated to assess the therapeutic effects of DPS. To explore its underlying mechanisms, colon contents 16S rRNA sequencing and serum untargeted metabolomics were performed. Results indicated that DPS significantly reduced lipid accumulation and inflammatory damage in the livers of NAFLD mice, improving both blood lipid profiles and oxidative stress. Network pharmacology analysis revealed that DPS primarily targets pathways associated with inflammation and oxidative stress, while molecular docking suggested its potential to inhibit the NF-\u03baB pathway activation and the expression of the receptor for advanced glycation end-products (RAGE), findings corroborated by Western blotting. Additionally, gut microbiota and serum metabolomics analyses demonstrated that DPS improved microbiota composition by increasing the abundance of beneficial bacteria, such as\n                    <jats:italic>Akkermansia<\/jats:italic>\n                    , and restored serum metabolomic balance, enhancing anti-inflammatory and antioxidant metabolites like Tretinoin and Pyridoxamine. The non-targeted metabolomics results suggest that DPS is mediated by glutathione metabolism, arginine and proline metabolism, unsaturated fatty acid biosynthesis, and linoleic acid metabolism interferes with NAFLD progression. In conclusion, DPS may alleviate oxidative stress and lipid accumulation in NAFLD mice through the AGEs\/RAGE\/NF-\u03baB pathway, while also ameliorating gut microbiota dysbiosis and serum metabolomic disturbances, fostering the production of anti-inflammatory and antioxidant metabolites.\n                  <\/jats:p>","DOI":"10.3389\/fnut.2025.1574151","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:11:30Z","timestamp":1748304690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["D-Psicose mitigates NAFLD mice induced by a high-fat diet by reducing lipid accumulation, inflammation, and oxidative stress"],"prefix":"10.3389","volume":"12","author":[{"given":"Jiajun","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"109125","DOI":"10.1016\/j.carres.2024.109125","article-title":"Trapping mechanism by di-d-psicose anhydride with methylglyoxal for prevention of diabetic nephropathy","volume":"540","author":"Jung","year":"2024","journal-title":"Carbohydr Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"130363","DOI":"10.1016\/j.biortech.2024.130363","article-title":"Optimizing bioconversion processes of rice husk into value-added products: D-psicose, bioethanol, and lactic acid","volume":"395","author":"Song","year":"2024","journal-title":"Bioresour Technol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e08013","DOI":"10.1016\/j.heliyon.2021.e08013","article-title":"Investigation of d-allulose effects on high-sucrose diet-induced insulin resistance via hyperinsulinemic-euglycemic clamps in rats","volume":"7","author":"Natsume","year":"2021","journal-title":"Heliyon"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/jn\/nxac026","article-title":"The role of D-allulose and erythritol on the activity of the gut sweet taste receptor and gastrointestinal satiation hormone release in humans: a randomized, controlled trial","volume":"152","author":"Teysseire","year":"2022","journal-title":"J Nutr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12934-024-02487-x","article-title":"Production, purification, characterization, and safety evaluation of constructed recombinant D-psicose 3-epimerase","volume":"23","author":"Watthanasakphuban","year":"2024","journal-title":"Microb Cell Factories"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/10408398.2020.1743966","article-title":"Rare mono- and disaccharides as healthy alternative for traditional sugars and sweeteners","volume":"61","author":"Van Laar","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"952147","DOI":"10.3389\/fnut.2022.952147","article-title":"Research progress on extraction technology and biomedical function of natural sugar substitutes","volume":"9","author":"Lei","year":"2022","journal-title":"Front Nutr"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/jof9090907","article-title":"Recent advances in the biosynthesis of natural sugar substitutes in yeast","volume":"9","author":"Li","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1039\/d0fo03024d","article-title":"Effect of D-allulose feeding on the hepatic metabolomics profile in male Wistar rats","volume":"12","author":"Kanasaki","year":"2021","journal-title":"Food Funct"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07388551.2024.2368517","article-title":"D-allulose 3-epimerase for low-calorie D-allulose synthesis: microbial production, characterization, and applications","volume":"45","author":"Xie","year":"2024","journal-title":"Crit Rev Biotechnol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann Transl Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.3390\/cells10123401","article-title":"Progressive liver fibrosis in non-alcoholic fatty liver disease","volume":"10","author":"Ramai","year":"2021","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher's guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat Metab"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"11128","DOI":"10.3390\/ijms222011128","article-title":"The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease","volume":"22","author":"Ziolkowska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"18983","DOI":"10.1038\/s41598-023-46404-5","article-title":"A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-\u03b2 signaling in hepatic stellate cells","volume":"13","author":"Kasahara","year":"2023","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving role for pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin Transl Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/joim.13380","article-title":"Inflammatory and fibrotic mechanisms in NAFLD-implications for new treatment strategies","volume":"291","author":"Lee","year":"2022","journal-title":"J Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"155835","DOI":"10.1016\/j.metabol.2024.155835","article-title":"Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges","volume":"154","author":"Kokkorakis","year":"2024","journal-title":"Metabolism"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/HEP.0000000000001112","article-title":"Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD practice guidance","volume":"81","author":"Chen","year":"2025","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"11689","DOI":"10.3390\/ijms231911689","article-title":"Current research on the pathogenesis of NAFLD\/NASH and the gut-liver axis: gut microbiota, dysbiosis, and leaky-gut syndrome","volume":"23","author":"Kobayashi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/biomedicines11020468","article-title":"Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and non-viral hepatocarcinoma: pathophysiological mechanisms and new therapeutic strategies","volume":"11","author":"Vetrano","year":"2023","journal-title":"Biomedicines"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.3390\/molecules28104042","article-title":"Lactiplantibacillus plantarum NKK20 alleviates high-fat-diet-induced nonalcoholic fatty liver disease in mice through regulating bile acid anabolism","volume":"28","author":"Sun","year":"2023","journal-title":"Molecules"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1222395","DOI":"10.1155\/2024\/1222395","article-title":"Inulin reduces kidney damage in type 2 diabetic mice by decreasing inflammation and serum metabolomics","volume":"2024","author":"He","year":"2024","journal-title":"J Diabetes Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol Int"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"eabo4474","DOI":"10.1126\/scitranslmed.abo4474","article-title":"Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease","volume":"14","author":"Fujiwara","year":"2022","journal-title":"Sci Transl Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.3390\/nu14245335","article-title":"Diet and risk of non-alcoholic fatty liver disease, cirrhosis, and liver cancer: a large prospective cohort study in UK biobank","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/antiox10040565","article-title":"Lingonberry improves non-alcoholic fatty liver disease by reducing hepatic lipid accumulation, oxidative stress and inflammatory response","volume":"10","author":"Madduma Hewage","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/antiox11112217","article-title":"Role of oxidative stress and lipid peroxidation in the pathophysiology of NAFLD","volume":"11","author":"Mart\u00edn-Fern\u00e1ndez","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"136186","DOI":"10.1016\/j.ijbiomac.2024.136186","article-title":"Bioactive proteins and antioxidant peptides from Litsea cubeba fruit meal: preparation, characterization and ameliorating function on high-fat diet-induced NAFLD through regulating lipid metabolism, oxidative stress and inflammatory response","volume":"280","author":"Li","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"770986","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and non-alcoholic fatty liver disease","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e14224","DOI":"10.1111\/eci.14224","article-title":"The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction-associated steatotic liver disease","volume":"54","author":"Bergheim","year":"2024","journal-title":"Eur J Clin Investig"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"17174","DOI":"10.3390\/ijms242417174","article-title":"Reduced lipopolysaccharide-binding protein (LBP) levels are associated with non-alcoholic fatty liver disease (NAFLD) and adipose inflammation in human obesity","volume":"24","author":"Barchetta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.cgh.2022.11.030","article-title":"Blood endotoxin levels as biomarker of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Soppert","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3390\/ijms25042183","article-title":"Microbial dysbiosis linked to metabolic dysfunction-associated fatty liver disease in Asians: Prevotella copri promotes lipopolysaccharide biosynthesis and network instability in the prevotella enterotype","volume":"25","author":"Yuan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.dld.2020.09.021","article-title":"Antioxidant activity of hydroxytyrosol and vitamin E reduces systemic inflammation in children with paediatric NAFLD","volume":"53","author":"Mosca","year":"2021","journal-title":"Dig Liver Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1144550","DOI":"10.3389\/fphar.2023.1144550","article-title":"Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: a randomized controlled trial","volume":"14","author":"Tutunchi","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/antiox13070797","article-title":"The role of antioxidants in the treatment of metabolic dysfunction-associated fatty liver disease: a systematic review","volume":"13","author":"Mohammadian","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/cells11081312","article-title":"Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs","volume":"11","author":"Twarda-Clapa","year":"2022","journal-title":"Cells"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","article-title":"AGE\/RAGE in diabetic kidney disease and ageing kidney","volume":"171","author":"Wu","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"111099","DOI":"10.1016\/j.foodres.2022.111099","article-title":"Role of glycated proteins in vivo: enzymatic glycated proteins and non-enzymatic glycated proteins","volume":"155","author":"Wu","year":"2022","journal-title":"Food Res Int"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3390\/biomedicines12081699","article-title":"Advanced glycation end-products acting as immunomodulators for chronic inflammation, inflammaging and carcinogenesis in patients with diabetes and immune-related diseases","volume":"12","author":"Shen","year":"2024","journal-title":"Biomedicines"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"8852759","DOI":"10.1155\/2021\/8852759","article-title":"The role of oxidative stress and antioxidants in diabetic wound healing","volume":"2021","author":"Deng","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1497449","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"Biomed Res Int"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"931473","DOI":"10.3389\/fimmu.2022.931473","article-title":"Pathophysiology of RAGE in inflammatory diseases","volume":"13","author":"Dong","year":"2022","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"975724","DOI":"10.3389\/fendo.2022.975724","article-title":"Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-\u03baB\/LCN-2 signaling pathway in inflammatory microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/a-2008-7948","article-title":"AGEs RAGE pathways: Alzheimer's disease","volume":"73","author":"Maheshwari","year":"2023","journal-title":"Drug Res (Stuttg)"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1007\/s00210-024-03595-6","article-title":"Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic target","volume":"398","author":"Sarkar","year":"2024","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s12264-022-00878-x","article-title":"Role of RAGE in the pathogenesis of neurological disorders","volume":"38","author":"Juranek","year":"2022","journal-title":"Neurosci Bull"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"107282","DOI":"10.1016\/j.phrs.2024.107282","article-title":"Activation and modulation of the AGEs-RAGE axis: implications for inflammatory pathologies and therapeutic interventions \u2013 a review","volume":"206","author":"Zhou","year":"2024","journal-title":"Pharmacol Res"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.3390\/ijms22158153","article-title":"Hypoxia and the receptor for advanced glycation end products (RAGE) signaling in cancer","volume":"22","author":"Taneja","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11010-020-03928-y","article-title":"AGE-RAGE synergy influences programmed cell death signaling to promote cancer","volume":"476","author":"Waghela","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12885-022-09675-1","article-title":"HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K\/AKT signaling pathway in MDA-MB-231 breast cancer cells","volume":"22","author":"Amornsupak","year":"2022","journal-title":"BMC Cancer"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s43018-023-00524-z","article-title":"Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway","volume":"4","author":"Park","year":"2023","journal-title":"Nat Cancer"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12033-021-00320-z","article-title":"Characterization of a recombinant D-Allulose 3-epimerase from Thermoclostridium caenicola with potential application in D-Allulose production","volume":"63","author":"Chen","year":"2021","journal-title":"Mol Biotechnol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3164\/jcbn.11-66","article-title":"The 90-day oral toxicity of d-psicose in male Wistar rats","volume":"50","author":"Matsuo","year":"2012","journal-title":"J Clin Biochem Nutr"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1080\/10408398.2023.2171362","article-title":"Low-calorie bulk sweeteners: recent advances in physical benefits, applications, and bioproduction","volume":"64","author":"Li","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.metabol.2009.07.018","article-title":"Failure of d-psicose absorbed in the small intestine to metabolize into energy and its low large intestinal fermentability in humans","volume":"59","author":"Iida","year":"2010","journal-title":"Metabolism"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"583943","DOI":"10.3389\/fmed.2020.583943","article-title":"CML\/RAGE signal bridges a common pathogenesis between atherosclerosis and non-alcoholic fatty liver","volume":"7","author":"Pang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"173874","DOI":"10.1016\/j.ejphar.2021.173874","article-title":"Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE\/TLR4-reactive oxygen species-activated NF-k\u03b2 nexus","volume":"894","author":"Jahan","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e14256","DOI":"10.1016\/j.heliyon.2023.e14256","article-title":"A standardized pomegranate fruit extract ameliorates thioacetamide-induced liver fibrosis in rats via AGE-RAGE-ROS signaling","volume":"9","author":"Abouelezz","year":"2023","journal-title":"Heliyon"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/antiox12030748","article-title":"Involvement of intracellular TAGE and the TAGE-RAGE-ROS axis in the onset and progression of NAFLD\/NASH","volume":"12","author":"Sakasai-Sakai","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11418-021-01602-1","article-title":"Investigations of AGEs' inhibitory and nephroprotective potential of ursolic acid towards reduction of diabetic complications","volume":"76","author":"Mazumder","year":"2022","journal-title":"J Nat Med"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.3390\/life13122291","article-title":"Flavonols as a potential pharmacological intervention for alleviating cognitive decline in diabetes: evidence from preclinical studies","volume":"13","author":"Horvat","year":"2023","journal-title":"Life (Basel)"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"117573","DOI":"10.1016\/j.jep.2023.117573","article-title":"Mechanistic role of Syzygium cumini (L.) Skeels in glycation induced diabetic nephropathy via RAGE-NF-\u03baB pathway and extracellular proteins modifications: a molecular approach","volume":"322","author":"Apte","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/antiox10081161","article-title":"Ursolic acid and related analogues: triterpenoids with broad health benefits","volume":"10","author":"Nguyen","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.4239\/wjd.v15.i10.2111","article-title":"Asiaticoside improves diabetic nephropathy by reducing inflammation, oxidative stress, and fibrosis: an in vitro and in vivo study","volume":"15","author":"Zhuang","year":"2024","journal-title":"World J Diabetes"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"578","DOI":"10.26355\/eurrev_201802_14267","article-title":"Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts","volume":"22","author":"Milione","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.3390\/ijms20205037","article-title":"Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end products","volume":"20","author":"Fernando","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/nu12020352","article-title":"Alteration of microbiome profile by D-allulose in amelioration of high-fat-diet-induced obesity in mice","volume":"12","author":"Han","year":"2020","journal-title":"Nutrients"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"H49","DOI":"10.1111\/j.1750-3841.2009.01434.x","article-title":"D-psicose, a sweet monosaccharide, ameliorate hyperglycemia, and dyslipidemia in C57BL\/6J db\/db mice","volume":"75","author":"Baek","year":"2010","journal-title":"J Food Sci"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.3390\/ijms23073832","article-title":"Crocetin prolongs recovery period of DSS-induced colitis via altering intestinal microbiome and increasing intestinal permeability","volume":"23","author":"Feng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3390\/nu16162660","article-title":"Exploration of the Muribaculaceae family in the gut microbiota: diversity, metabolism, and function","volume":"16","author":"Zhu","year":"2024","journal-title":"Nutrients"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"e2100136","DOI":"10.1002\/mnfr.202100136","article-title":"Ligilactobacillus Salivarius LCK11 prevents obesity by promoting PYY secretion to inhibit appetite and regulating gut microbiota in C57BL\/6J mice","volume":"65","author":"Liang","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"10361","DOI":"10.1021\/acs.jafc.3c03149","article-title":"Modulation of the microbiome-fat-liver axis by lactic acid bacteria: a potential alleviated role in high-fat-diet-induced obese mice","volume":"71","author":"Wei","year":"2023","journal-title":"J Agric Food Chem"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"eabk0855","DOI":"10.1126\/scitranslmed.abk0855","article-title":"Risk assessment with gut microbiome and metabolite markers in NAFLD development","volume":"14","author":"Leung","year":"2022","journal-title":"Sci Transl Med"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","article-title":"Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis","volume":"35","author":"Kuang","year":"2023","journal-title":"Cell Metab"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"2221485","DOI":"10.1080\/19490976.2023.2221485","article-title":"Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated \u03b3\u03b4T17 cell and macrophage polarization","volume":"15","author":"Han","year":"2023","journal-title":"Gut Microbes"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1379064","DOI":"10.3389\/fmicb.2024.1379064","article-title":"Multi-omics analysis of the biological mechanism of the pathogenesis of non-alcoholic fatty liver disease","volume":"15","author":"Lin","year":"2024","journal-title":"Front Microbiol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3945\/ajcn.114.105155","article-title":"Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease","volume":"102","author":"Liu","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/21623945.2021.2015864","article-title":"Adipose tissue plays a major role in retinoic acid-mediated metabolic homoeostasis","volume":"11","author":"Zhu","year":"2022","journal-title":"Adipocytes"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/s11427-016-9027-6","article-title":"Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1","volume":"60","author":"Geng","year":"2017","journal-title":"Sci China Life Sci"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1748065","DOI":"10.1155\/2016\/1748065","article-title":"Vitamin B6 prevents endothelial dysfunction, insulin resistance, and hepatic lipid accumulation in apoe (\u2212\/\u2212) mice fed with high-fat diet","volume":"2016","author":"Liu","year":"2016","journal-title":"J Diabetes Res"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0271678X221130124","article-title":"Pyridoxamine treatment ameliorates large artery stiffening and cerebral artery endothelial dysfunction in old mice","volume":"43","author":"Reeve","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000512832","article-title":"Pyridoxamine and caloric restriction improve metabolic and microcirculatory abnormalities in rats with non-alcoholic fatty liver disease","volume":"58","author":"Pereira","year":"2021","journal-title":"J Vasc Res"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"e12603","DOI":"10.1111\/micc.12603","article-title":"Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease","volume":"27","author":"Pereira","year":"2020","journal-title":"Microcirculation"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/HCO.0b013e3283398e53","article-title":"Statins and inflammation: an update","volume":"25","author":"Quist-Paulsen","year":"2010","journal-title":"Curr Opin Cardiol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11883-021-00977-6","article-title":"Statins and inflammation","volume":"23","author":"Satny","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"166750","DOI":"10.1016\/j.bbadis.2023.166750","article-title":"Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway","volume":"1869","author":"Kitsugi","year":"2023","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1158\/1940-6207.CAPR-20-0600","article-title":"A novel biomarker panel for the early detection and risk assessment of hepatocellular carcinoma in patients with cirrhosis","volume":"14","author":"Khan","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MCG.0b013e31815591aa","article-title":"Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis","volume":"42","author":"Tanaka","year":"2008","journal-title":"J Clin Gastroenterol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1574151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:11:31Z","timestamp":1748304691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1574151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":95,"alternative-id":["10.3389\/fnut.2025.1574151"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1574151","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"article-number":"1574151"}}